Regulatory mechanisms of high-polyphenol dietary intervention on exercise-induced immunosuppression during high-intensity training periods in adolescent athletes

ISRCTN ISRCTN89562119
DOI https://doi.org/10.1186/ISRCTN89562119
Sponsor Chizhou University
Funder Chizhou University
Submission date
15/05/2026
Registration date
19/05/2026
Last edited
18/05/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study will test whether a daily high-polyphenol supplement can help protect adolescent athletes from temporary weakening of the immune system during periods of high-intensity training. The main goal is to determine whether the supplement helps maintain immune balance and reduce training-related immune suppression during heavy training.

Who can participate?
Healthy adolescent athletes aged 15–17 years

What does the study involve?
Participants will be randomly assigned to receive either the polyphenol supplement or a placebo for 12 weeks. The study team will compare changes in immune function, inflammation, salivary immune markers, gut microbiome, metabolism, and upper respiratory tract infection occurrence at baseline and during follow-up at weeks 4, 8, and 12.

What are the possible benefits and risks of participating?
Benefits and risks not provided at time of registration

Where is the study run from?
Jiangxi University of Science and Techonology, China.

When is the study starting and how long is it expected to run for?
September 2024 to May 2025.

Who is funding the study?
Chizhou University, China.

Who is the main contact?
Mr Qinshan Huang, huangqinshan@jxust.edu.cn

Contact information

Mr Lei He
Public

Wanju-gun 55338, Jeollabuk-do
Wanju-gun
55338
Korea, South

Phone +8201058363886
Email 1140907063@qq.com
Mr Shun Yue
Principal investigator, Scientific

No. 998 Fangxing Avenue, Hefei Economic and Technological Development Zone
Hefei City, Anhui Province
230061
China

Phone +86 17681204090
Email 19154011075@163.com
Mr Qinshan Huang
Principal investigator

No. 1180, Shuanggang East Street, Changbei Development Zone
Nanchang City, Jiangxi Province
330013
China

Phone +86 17681204090
Email huangqinshan@jxust.edu.cn
Mr Jiahong Wu
Scientific

No. 199, Muzhilu Road, Guichi District
Chizhou City, Anhui Province
247000
China

Phone +86 17681204090
Email 936667979@qq.com

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlPlacebo
AssignmentCrossover
PurposeBasic science, Prevention
Scientific titleRegulatory mechanisms of high-polyphenol dietary intervention on exercise-induced immunosuppression during high-intensity training periods in adolescent athletes: a systems biology analysis based on immune-metabolic pathways
Study objectives The purpose of this study is to evaluate whether a 12-week high-polyphenol dietary intervention can prevent or attenuate exercise-induced immunosuppression in adolescent athletes undergoing high-intensity training. The study aims to determine whether supplementation helps maintain immune homeostasis, reduce inflammatory and mucosal immune disturbances, modulate gut microbiota and short-chain fatty acid production, and identify potential immune-metabolic biomarkers associated with individual responses to the intervention.
Ethics approval(s)

Approved 15/01/2024, Ethics Committee of Chizhou University (No. 199, Muzhilu Road, Guichi District, Chizhou City, Anhui Province, 247000, Korea, South; -; ma056789024@163.com), ref: cz20240733

Health condition(s) or problem(s) studiedExercise-induced immunosuppression in adolescent athletes during periods of high-intensity training, particularly immune homeostasis disruption, reduced mucosal immune protection, inflammatory and oxidative stress responses, altered T-cell balance, gut microbiome changes, and increased susceptibility to upper respiratory tract infections.
InterventionParticipants were randomly allocated in a 1:1 ratio to either the high-polyphenol dietary intervention group or the placebo group. Randomisation was stratified by sex, sport discipline, and baseline immune function. The random allocation sequence was generated using a computer-based randomisation program by an independent researcher who was not involved in participant recruitment, intervention delivery, outcome assessment, or data analysis. Allocation concealment was maintained using sequentially numbered, opaque, sealed envelopes. Participants, coaches, investigators, laboratory staff, and outcome assessors were blinded to group allocation throughout the trial.

The intervention group received a high-polyphenol dietary supplement containing 1200 mg/day in total: quercetin 300 mg/day, EGCG 400 mg/day, resveratrol 200 mg/day, and curcumin 300 mg/day. The supplement was administered as two 600 mg doses per day, taken at approximately 07:00 and 19:00 with meals, during the 12-week high-intensity training period. Participants were instructed to take the supplement with at least 10 g of dietary fat and to avoid calcium-rich foods, iron supplements, and polyphenol-rich beverages within two hours of administration.

The placebo group received matched placebo capsules containing microcrystalline cellulose, identical in appearance, packaging, and administration schedule to the active supplement. Compliance was monitored using electronic medication event monitoring systems, bi-weekly pill counts, and urinary polyphenol metabolite assessment at weeks 4, 8, and 12.
The intervention was delivered during a 12-week periodized high-intensity training programme, including a preparatory phase, competition/peak-load phase, and recovery phase. Training load was monitored using session rating of perceived exertion multiplied by training duration, and heart-rate-based training impulse.

Blood samples were collected at the following timepoints:
Baseline/week 0: before the intervention
Week 4: end of the preparatory phase
Week 8: end of the peak-load competition phase
Week 12: end of the recovery phase / longitudinal follow-up
To reduce the influence of acute exercise responses, biological samples were collected 36–48 hours after the last training session of each phase, following an overnight fast of at least 10 hours. All sample collection procedures were performed between 06:00 and 08:00.
Intervention typeSupplement
Primary outcome measure(s)
  1. CD4+/CD8+ T-cell ratio measured using flow cytometric immunophenotyping of EDTA-anticoagulated peripheral blood samples at baseline, week 4, week 8, and week 12. The primary comparison is the change in CD4+/CD8+ T-cell ratio from baseline to week 8.
Key secondary outcome measure(s)
  1. Peripheral blood T-cell subsets, including CD4+ T cells, CD8+ T cells, regulatory T cells, and Th17 cells measured using flow cytometric immunophenotyping at baseline, week 4, week 8, and week 12
  2. Peripheral blood natural killer cell count and percentage measured using flow cytometric immunophenotyping at baseline, week 4, week 8, and week 12
  3. Salivary IgA measured using laboratory assays at baseline, week 4, week 8, and week 12
  4. Inflammatory and immune-related biomarkers in blood samples measured using laboratory assays at baseline, week 4, week 8, and week 12
  5. Metabolomic, proteomic, transcriptomic, and microbiome-related markers in blood, urine, and/or fecal samples measured using omics platforms at baseline, week 4, week 8, and week 12, as applicable to each platform
  6. Upper respiratory tract infection incidence measured using data recorded during the 12-week intervention period, and collected at one time point
Completion date15/05/2025

Eligibility

Participant type(s)
Age groupChild
Lower age limit15 Years
Upper age limit17 Years
SexAll
Target sample size at registration80
Total final enrolment75
Key inclusion criteriaAdolescent athletes aged 15–17 years who met all of the following criteria:
1. At least 3 years of systematic training experience
2. Participation in provincial-level competition within the previous 12 months
3. Weekly training volume of ≥10 hours
4. Tanner stage III–V pubertal development
Key exclusion criteria1. An acute infection within the previous 4 weeks
2. Chronic inflammatory or autoimmune disease
3. Regular medication or supplement use that could affect immune function
4. A history of overtraining syndrome
5. A musculoskeletal injury that prevented normal training
Date of first enrolment15/09/2024
Date of final enrolment15/12/2024

Locations

Countries of recruitment

  • China

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

18/05/2026: Study’s existence confirmed by the Ethics Committee of Chizhou University, China.